| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |